Project Grant R00DA060983
- Federal Project Grant Award Summary The Medical University of South Carolina received a $210,168 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 1, 2026, with completion scheduled for April 30, 2028. This award supports research aimed at dissecting glutamatergic pathway-specific neural ensembles that guide motivated behavior and drug-seeking in the context of opioid use disorder (OUD). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $192,149 Project Grant to the University of South Carolina effective February 1, 2026, through January 31, 2028, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research project investigates the noradrenergic mechanisms underlying stress-induced opioid reinstatement, addressing the neural pathways through which traumatic stress and comorbid neuropsychiatric conditions—including anxiety,...
- Federal Grant Award Summary The Medical University of South Carolina received a $675,129 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective April 1, 2026, through January 31, 2031. This award supports research and development of an integrated, trauma-focused behavioral intervention titled Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure for Adolescents (COPE-A). The project...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $182,249 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 15, 2025, through June 30, 2029. This award supports the implementation and evaluation of EMPWR (Empowering Pregnant Women Receiving Medications for Opioid Use Disorder), a digitally enhanced intervention designed to improve buprenorphine treatment retention among...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Medical University of South Carolina a Project Grant totaling $686,692 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct prospective research on cannabis use reduction and its impact on patient functioning. Initiated on September 1, 2025, and extending through July 31, 2030, this eight-week clinical trial will enroll 176 adults aged 18 and older with Cannabis Use Disorder...
- Federal Grant Award Summary Clemson University's Division of Research received a $353,508 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2025, with a completion date of May 31, 2030. This K01 Career Development Award supports an Assistant Professor's research and professional development plan focused on electronic cigarettes (ECs) as a harm reduction strategy for individuals with opioid use...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $200,676 K23 Career Development Grant to the University of Wisconsin–Madison on September 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). This five-year award supports the development of machine learning approaches to advance personalized smoking cessation risk prediction and intervention in adults attempting to quit smoking. The research leverages existing datasets from diverse adult...
- Federal Project Grant Award Summary Boston University Medical Campus has been awarded $193,752 by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on adolescent exposure to nicotine and tobacco content on social media. The project, which commenced February 15, 2026, and extends through January 31, 2031, will develop comprehensive exposure assessment methodologies that integrate adolescent experiences with social...
- Federal Project Grant Award Summary The University of Arkansas received a $418,372 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning September 1, 2025, and extending through August 31, 2030. This K23 Career Development Award funds a translational research evaluation examining the intersection of depressive symptomatology and smoking cessation treatment mechanisms using just-in-time adaptive...
- Federal Project Grant Award Summary Wake Forest University Health Sciences received a $105,076 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective December 1, 2025, with a completion date of December 31, 2027. This fellowship award supports research investigating the neurocomputational basis of effort-based decision making (EBDM) in individuals with tobacco use disorder (TUD), concurrent tobacco and...
Federal Project Grant Award Summary The Medical University of South Carolina received a $249,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct research on social-contextual stressors affecting smoking cessation among socioeconomically disadvantaged young adults (SDYA). Awarded June 1, 2026, with a completion date of May 31, 2029, this K99/R00 grant supports a mixed-methods research initiative combining qualitative interviews and ecological momentary assessment (EMA) protocols to examine how daily variations in social-contextual stressors—such as financial stress—impact smoking cessation and relapse risk in this high-risk population. The research deliverables include in-depth qualitative findings documenting the lived experiences of SDYA who smoke and attempt to quit, along with an EMA protocol designed to capture real-time data on social-contextual stressors in naturalistic environments. The project aims to generate empirical evidence aligned with NIDA's strategic priorities regarding social determinants of health and addiction risk across the lifespan, ultimately providing evidence-based insights to inform smoking cessation interventions tailored to socioeconomically disadvantaged populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $249.0k | 6/1/26 |